Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1002/doi2.89 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1867006218602545152 |
|---|---|
| author | Iskandar Idris |
| author_facet | Iskandar Idris Iskandar Idris |
| collection | Wiley Open Access |
| contents | Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease Iskandar Idris Diabetes, Obesity and Metabolism Now 10.1002/doi2.89 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/doi2.89 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_doi2_89 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease Iskandar Idris Diabetes, Obesity and Metabolism Now Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease Iskandar Idris Diabetes, Obesity and Metabolism Now 10.1002/doi2.89 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease |
| topic | Diabetes, Obesity and Metabolism Now |
| url | https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1002/doi2.89 |